33043

Pharnext to Present at 7th Annual CEC Capital Summit

14/09/2017 - 12:40

Regulatory News:

Pharnext SA (Paris:ALPHA) (FR00111911287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drugs based on the combination and repositioning of known drugs, today announced that company management will present a corporate overview at the 7th Annual CEC Capital Summit.

The presentation will take place as follows:

  • Date: Wednesday, September 20th, 2017
  • Time: 2:50 pm PDT (11:50 pm CEST)
  • Venue: Montage Beverly Hills in Beverly Hills, California

If you are interested in meeting the Pharnext management team during this event, please send an email to Matthew Shinseki at matthew@sternir.com.

About Pharnext
Pharnext is an advanced clinical-stage biopharmaceutical company founded by renowned scientists and entrepreneurs including Professor Daniel Cohen, a pioneer in modern genomics. Pharnext has two lead products in clinical development. PXT3003 is currently in an international Phase 3 trial for the treatment of Charcot-Marie-Tooth disease type 1A and benefits from orphan drug status in Europe and the United States. PXT864 has generated positive Phase 2 results in Alzheimer’s disease. Pharnext is the pioneer of a new drug discovery paradigm: PLEOTHERAPY™. The Company identifies and develops synergic combinations of repositioned drugs at new optimal lower doses. These PLEODRUG™ offer several key advantages: efficacy, safety and intellectual property including several product or composition of matter patents already granted. The Company is supported by a world-class scientific team.

The company Pharnext is listed on Euronext Growth Stock Exchange in Paris (ISIN code: FR00111911287).
For more information, visit www.pharnext.com

 


PUBLICIDAD


Contenido patrocinado

Otras noticias








El flash: toda la última hora

Boletines


Todos los boletines





Prima de Riesgo
País Precio Puntos %
ESP 91,66 +1,92 +2,13%
FRA 29,95 +2,76 +10,16%
ITA 187,25 +10,43 +5,90%
GRE 385,26 +2,41 +0,63%
POR 142,92 +2,76 +1,97%

Ecotrader



Evasión

Las fiestas de las criptomonedas

Las fiestas de las criptomonedas



Copyright 2006-2016, Editorial Ecoprensa, S.A. | Política de Privacidad | Aviso Legal | Política de cookies | Cloud Hosting en Acens